Stocksigma LogoStocksigma Logo

Camlin Fine Sciences Board to Consider Q2 Results and Rights Issue

Camlin Fine Sciences has scheduled its Board of Directors meeting for 3rd Nov'26 to evaluate and approve the unaudited standalone and consolidated

Camlin Fine Sciences Board to Consider Q2 Results and Rights Issue

Camlin Fine Sciences Ltd 路 Intimation 路 03 Nov 2026, 5:30 am

Camlin Fine Sciences Board to Consider Q2 Results and Rights Issue Camlin Fine Sciences has scheduled its Board of Directors meeting for 3rd Nov'26 to evaluate and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. Additionally, the board will consider a fundraising proposal via a rights issue of equity shares or other securities, subject to regulatory approvals. The company's trading window remains closed for designated persons from 1st Oct'26 through 5th Nov'26.

Original exchange filing (PDF)

More announcements from Camlin Fine Sciences Ltd

All Camlin Fine Sciences Ltd announcements